Kyoto University News
-
Retina Institute Japan K.K., which is employing Nobel Prize-winning stem-cell technology to treat eye diseases, plans to sell a stake in itself to a group of Japanese companies next month ahead of a possible initial public offering in five years.
-
Japan’s ruling Liberal Democratic Party has removed most anti-nuclear researchers from a revamped post-Fukushima energy policy advisory board to the government that resumes discussions today.
-
Japan’s proposal to cut the price paid for solar power by 10 percent leaves in place incentives for a boom in installations this year, the industry’s lobby group said.
-
Japan’s solar developers would get 10 percent less for the power they feed to utilities under a recommendation a government panel made after taking into account a plunge in the cost of panels.
-
John B. Gurdon transferred DNA between a tadpole and a frog to clone the first animal. Shinya Yamanaka used Gurdon’s concept to turn ordinary skin into potent stem cells. Both won the Nobel Prize for medicine today.
-
Tetsuro Fujita’s eureka moment about a Himalayan fungus in 1985 may mean part of a $5 billion payout for Mitsubishi Tanabe Pharma Corp. a quarter-century later.
-
Julian Robertson, whose firm Tiger Management LLC has bred some highly successful “cub” money managers, discouraged that career path in an interview last night.
-
Tokyo Electric Power Co. said the containment chambers of damaged reactors at its Fukushima nuclear plant were likely breached, identifying additional source of radiation leaks that may exceed Chernobyl.
-
Japan has an advantage as a “latecomer” introducing incentives to promote renewable energy investments, the chairman of a government panel overseeing the setting of rates for clean energy said today.
-
Stem cells derived from a mouse’s skin won Shinya Yamanaka the Nobel Prize yesterday. Now researchers in Japan are seeking to use his pioneering technology for an even greater prize: restoring sight.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page